Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
To reach that milestone, researchers are continuing to refine peptide-based oral formulations
Goes best with Weight Management Retatrutide Triple agonist GLP-1/GIP/glucagon for weight management Format Size SKU RT5 Same-day Bali dispatch before 5 PM Lab-tested for purity Discreet, temperature-aware packaging Description + Retatrutide is an investigational triple-agonist peptide that simultaneously targets the GLP-1, GIP, and glucagon receptors
Rubino DM, Greenway FL, Khalid U, ONeil PM, Rosenstock J, Srrig R, et al
Lomaira comes in 8 mg oral capsules that you take up to three times per day with food
Rosenstock J (2023)
For example, in December 2024, Novo Nordisk bought three Catalent sites for US$11bn in order to boost its injectable drug capacity, and in December 2025, Eli Lilly announced new plans to build a US$6bn manufacturing facility in the US
US$ 27.02
US$ 23.83
US$ 24.17
US$ 26.37
US$ 21.01
US$ 29.04
